1. Evidence Based
1.1. How strong is the evidence about the distribution and cause of the problem, its prevention and its management?
1.2. Critical appraisal of different medical articles
1.3. Critically appraise prevention effectiveness and strategies
1.4. Critically appraise protocols and clinical guidelines
1.5. Suggest area for further research
2. lecture guideline
2.1. Distribution
2.1.1. Definition
2.1.2. Enumerate types of blood-born diseases
2.1.3. Identify the global and national magnitude of the blood-born diseases
2.2. Cause
2.2.1. What causes the problem?
2.2.1.1. through a vector
2.2.1.2. blood transfusion
2.2.1.3. contaminated needles
2.2.2. List causes of blood-born diseases
2.2.3. Identify the risk of used injections
2.2.4. Learn the risk of sharp medical waste and other medical wastes
2.3. Impact
2.3.1. Personal Effects
2.3.1.1. What are the personal effects of having the problem?
2.3.1.2. Health related outcomes in the individual:
2.3.1.2.1. Potential years of life lost (PYLL)
2.3.1.2.2. Quality of life
2.3.1.3. Individual patient response to illness/injury:
2.3.1.3.1. Areas of impact
2.3.2. Societal Effects
2.3.2.1. What are the effects of the problem (and its management) on, and in, society?
2.3.2.2. Burden of illness
2.3.2.3. Financial impact
2.3.2.4. Effects on family structures, stigmatization, discrimination, litigation...etc.
2.4. Societal Response to the problem
2.4.1. How does (and could) society respond to the problem?
2.4.2. Impact of non-health policies
2.5. Management
2.5.1. What is the most appropriate management of the problem at individual system & population levels, and how can systems be continually improved?
2.5.2. Describe strategies used to manage this problem (locally and internationally, compare)
2.5.3. Influences of decision-Making (Political, Media, Ethical...) Clinical protocols / guidelines.
2.6. Prevention
2.6.1. How can the problem be prevented?
2.6.2. Outline current practice for prevention in Saudi Arabia
2.6.3. Define the role of the community to prevent this problem
2.6.4. Compare with other health systems / societies
3. Studies
3.1. GLOBAL
3.1.1. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
3.1.2. Hepatitis C virus infection in the Amazon Brazilian region
3.1.3. Hepatitis C virus infection in Eastern Europe
3.1.4. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
3.1.5. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
3.1.6. Epidemiology of occult hepatitis B infection among thalassemic, hemophilia, and hemodialysis patients
3.1.7. Bias of medical students in Russia
3.1.8. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges
3.2. LOCAL
3.2.1. Stigmatization of persons with HIV/AIDS in Saudi Arabia
3.2.2. Epidemiology of viral hepatitis in Saudi Arabia: Are we off the hook?
3.2.3. Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades
3.2.4. Prevalence of hepatitis B and C among students of health colleges in Saudi Arabia